ALIA PORTER: Open Payments
NPI 1871116582 · AUGUSTA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 21 payments from 10 companies in 2025. Trend: 2023 $166 · 2024 $186 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $95 |
| AstraZeneca Pharmaceuticals LP | 5 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Astellas Pharma US Inc | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| TOLMAR, INC. | 1 | $14 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: BEXSERO, XIFAXAN, BREZTRI, Veozah, AIRSUPRA, KEVEYIS, Cologuard Collection Kit, PREVNAR 20.
Industry payments across KS — which companies pay providers there.
